Showing results (201-210 of 348) with videos related to
Sort By:
Pageof 35
Journal of Medicinal Chemistry|August 18, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping GroupsNina Reßing, Melf Sönnichsen, Jeremy D Osko, et al.European Journal of Human Genetics : EJHG|January 6, 2018
Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6Julia Taeubner, Katharina Wimmer, Martine Muleris, et al.Cell Death & Disease|September 20, 2022
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumorsLena Blümel, Nan Qin, Johannes Berlandi, et al.British Journal of Haematology|September 20, 2011
Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective surveyKlaus Bienemann, Birgit Burkhardt, Simon Modlich, et al.Journal of Medicinal Chemistry|September 28, 2021
4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug LeadsLinda Schäker-Hübner, Robin Warstat, Heinz Ahlert, et al.Haematologica|August 11, 2018
The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cellsDeborah Ingenhag, Sven Reister, Franziska Auer, et al.Viruses|April 30, 2021
Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2Julia Werner, Raphael M Kronberg, Pawel Stachura, et al.Haematologica|August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study GroupGabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.Journal of Medicinal Chemistry|November 9, 2022
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute LeukemiaNina Reßing, Julian Schliehe-Diecks, Paris R Watson, et al.Heliyon|July 29, 2024
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screeningAthanasios Oikonomou, Titus Watrin, Luigia Valsecchi, et al.Pageof 35